At a Glance: Presented By: Dr Alice Garrett Speaker Biography: Alice is a Clinical Cancer Geneticist, currently working as a Locum Consultant ... 05/19/2020 Rachid Karam from Ambry Genetics about his npj Precision Oncology paper "Splicing profile by capture RNA-seq ...

Mi Oncoseq Identifying Pathogenic Germline Variants -

Presented By: Dr Alice Garrett Speaker Biography: Alice is a Clinical Cancer Geneticist, currently working as a Locum Consultant ... 05/19/2020 Rachid Karam from Ambry Genetics about his npj Precision Oncology paper "Splicing profile by capture RNA-seq ... Presented By: Chelsea Alexander, MS, CGC Aarthi Goverdhan, PhD Speaker Biography: Chelsea Alexander, MS, CGC is a ...

Important details found

  • Presented By: Dr Alice Garrett Speaker Biography: Alice is a Clinical Cancer Geneticist, currently working as a Locum Consultant ...
  • 05/19/2020 Rachid Karam from Ambry Genetics about his npj Precision Oncology paper "Splicing profile by capture RNA-seq ...
  • Presented By: Chelsea Alexander, MS, CGC Aarthi Goverdhan, PhD Speaker Biography: Chelsea Alexander, MS, CGC is a ...
  • Genetics and genomics knowledge is crucial to understanding cancer development, diagnosis, prognosis, and treatment.
  • Samir Parekh, MD, Icahn School of Medicine, Mount Sinai, New York City, NY, discusses the discovery of

Why this topic is useful

This topic is useful when readers need a quick overview first, then want to move into supporting details and related references.

Sponsored

Frequently Asked Questions

Why are related topics included?

Related topics help readers compare nearby references and understand the broader subject.

What is this page about?

This page summarizes Mi Oncoseq Identifying Pathogenic Germline Variants and connects it with related entries, references, and supporting context.

Is the information always complete?

Not always. Some topics may need verification from official or primary sources.

Visual References

MI-ONCOSEQ: identifying pathogenic germline variants
Capture RNA-seq splicing profile identifies pathogenic germline variants in tumor suppressor genes
The discovery of pathogenic germline variants in patients with myeloma
Laboratory Methods & Variant Classifications in Cancer Genetic Testing
Variant Interpretation in Cancer Susceptibility Genes
#GeneticsGenomics: Germline and Somatic Testing
Detecting Variability in Tumor Genotyping Using NGS Platforms - Dr. J Frampton
Tumor Testing/Germline Significance
Variant interpretation, literature curation, and clinical trials, oh my! How to simplify somatic...
Whole-Exome Sequencing to Identify Somatic Variants in Cancer - Yardena Samuels
Sponsored
View Full Details
MI-ONCOSEQ: identifying pathogenic germline variants

MI-ONCOSEQ: identifying pathogenic germline variants

Read more details and related context about MI-ONCOSEQ: identifying pathogenic germline variants.

Capture RNA-seq splicing profile identifies pathogenic germline variants in tumor suppressor genes

Capture RNA-seq splicing profile identifies pathogenic germline variants in tumor suppressor genes

05/19/2020 Rachid Karam from Ambry Genetics about his npj Precision Oncology paper "Splicing profile by capture RNA-seq ...

The discovery of pathogenic germline variants in patients with myeloma

The discovery of pathogenic germline variants in patients with myeloma

Samir Parekh, MD, Icahn School of Medicine, Mount Sinai, New York City, NY, discusses the discovery of

Laboratory Methods & Variant Classifications in Cancer Genetic Testing

Laboratory Methods & Variant Classifications in Cancer Genetic Testing

Read more details and related context about Laboratory Methods & Variant Classifications in Cancer Genetic Testing.

Variant Interpretation in Cancer Susceptibility Genes

Variant Interpretation in Cancer Susceptibility Genes

Presented By: Dr Alice Garrett Speaker Biography: Alice is a Clinical Cancer Geneticist, currently working as a Locum Consultant ...

#GeneticsGenomics: Germline and Somatic Testing

#GeneticsGenomics: Germline and Somatic Testing

Genetics and genomics knowledge is crucial to understanding cancer development, diagnosis, prognosis, and treatment.

Detecting Variability in Tumor Genotyping Using NGS Platforms - Dr. J Frampton

Detecting Variability in Tumor Genotyping Using NGS Platforms - Dr. J Frampton

Read more details and related context about Detecting Variability in Tumor Genotyping Using NGS Platforms - Dr. J Frampton.

Tumor Testing/Germline Significance

Tumor Testing/Germline Significance

Excerpt from the January 2021 ICARE Genetics Case Conference focused on Tumor Testing and

Variant interpretation, literature curation, and clinical trials, oh my! How to simplify somatic...

Variant interpretation, literature curation, and clinical trials, oh my! How to simplify somatic...

Presented By: Chelsea Alexander, MS, CGC Aarthi Goverdhan, PhD Speaker Biography: Chelsea Alexander, MS, CGC is a ...

Whole-Exome Sequencing to Identify Somatic Variants in Cancer - Yardena Samuels

Whole-Exome Sequencing to Identify Somatic Variants in Cancer - Yardena Samuels

September 28, 2011. Next-Gen 101: Video Tutorial on Conducting Whole-Exome Sequencing Research More: ...